Sonesitatug vedotin Clinical Trials (2026): 1 Studies for Esophageal Cancer & Gastric Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Sonesitatug vedotin clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Esophageal Cancer & Gastric Cancer) and 2,130 total planned enrollment. 1 Phase 3 Sonesitatug vedotin trial are listed. 1 Sonesitatug vedotin clinical trial is actively recruiting at 4 U.S. sites across 4 states. Most recent activity: NCT07431281 (Oct 2031).
Where to Participate: All Sonesitatug vedotin Trial Sites in the U.S. (4 sites across 4 states)
Every actively recruiting Sonesitatug vedotintrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| MI | Research Site | Grand Rapids49503 | NCT07431281 | Map |
| MO | Research Site | St Louis63110 | NCT07431281 | Map |
| NJ | Research Site | East Brunswick08816 | NCT07431281 | Map |
| TN | Research Site | Nashville37203 | NCT07431281 | Map |
Sonesitatug vedotin clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P3 | 1 | 1 |
Recruiting Sonesitatug vedotin clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 | P3 | Gastric Cancer | 2,130 | Feb 2026 |
All Sonesitatug vedotin trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 | P3 | recruiting | 2,130 | AstraZeneca | Feb 2026 |
Sonesitatug vedotin clinical trials: frequently asked questions
- How many Sonesitatug vedotin clinical trials are there?
- 1 Sonesitatug vedotin clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Sonesitatug vedotin clinical trials recruiting in 2026?
- Yes — 1 Sonesitatug vedotin trial is actively recruiting in 2026, with 4 U.S. sites across 4 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Sonesitatug vedotin being studied for?
- Sonesitatug vedotin is being studied for Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma. The trials are grouped by indication on this page.
- What phase is Sonesitatug vedotin in?
- Sonesitatug vedotin clinical trials span 1 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Sonesitatug vedotin clinical trials?
- The lead sponsor across the most Sonesitatug vedotin trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Sonesitatug vedotinas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: